NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
6.91
-0.52 (-7.00%)
At close: Aug 13, 2025, 4:00 PM
6.75
-0.16 (-2.32%)
Pre-market: Aug 14, 2025, 9:05 AM EDT
NanoVibronix Employees
NanoVibronix had 31 employees as of December 31, 2024. The number of employees increased by 15 or 93.75% compared to the previous year.
Employees
31
Change (1Y)
15
Growth (1Y)
93.75%
Revenue / Employee
$85,871
Profits / Employee
-$181,032
Market Cap
5.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NAOV News
- 6 days ago - NanoVibronix Announces Reverse Stock Split - Business Wire
- 27 days ago - NanoVibronix Announces Financing of up to $50 Million Private Placement of Preferred Stock - Business Wire
- 7 weeks ago - NanoVibronix Announces ENvue Drive – First Intelligent Robotic Platform in Development for Bedside Feeding Tube and Vascular Line Navigation - Business Wire
- 7 weeks ago - NanoVibronix's ENvue Medical Division Announces Agreement with New York Medical Center to Implement ENvue™ Navigation Systems for Enteral Feeding Tube Placement - Business Wire
- 2 months ago - ENvue Medical Granted U.S. Patent for Pediatric Feeding Tube Guidance System - Business Wire
- 2 months ago - NanoVibronix Announces CEO Transition - Business Wire
- 2 months ago - NanoVibronix Responds to False Post - Business Wire
- 2 months ago - Major Louisiana Hospital Selects ENvue System for Feeding Tube Procedures - Business Wire